PSYCHOLOGICAL IMPACT OF
THYROID EYE DISEASE (TED)

The burden of TED runs deeper than you may think

Image of Rick, a real patient, talking about the burden of Thyroid Eye Disease

“TED was making my eyes bulge and sag, and puff out. Most of that I was okay with and thought I’d just be able to put up with it. But the double vision, blurry eyes, and never-ending tearing were unacceptable.”

—Rick, a TED patient

TED can be associated with significant psychological and emotional effects, including feelings of isolation, anxiety, or depression1,2

  • Mild symptoms of TED are often misdiagnosed and can lead to significant delays in treatment of TED3
  • Symptoms of TED extend beyond functional issues, and the psychosocial impact associated with the disease can affect many aspects of patient well-being1,3
  • Symptoms of TED can negatively impact employment, relationships, and self-confidence, which frequently lead to patients withdrawing from social interactions1,4

“I fell into a depression. It was never something I wanted to admit, but I started withdrawing and isolating myself. I became paranoid. No matter what I did, my eyes continued to change.” —Sally, a TED patient

Preview image of a video where Olympic gold medalist, Gail Devers, and TED Specialist, Dr Gary Lelli, discuss the negative impact of treating TED as a watch and wait disease

Three-time Olympic gold medalist, Gail Devers, and TED Specialist, Dr Gary Lelli, discuss the negative impact of treating TED as a "watch and wait" disease.

READ TRANSCRIPT

EMOTIONALLY… IT TAKES A TOLL. I DIDN’T LIKE LOOKING AT THE WAY I LOOKED…AND I DIDN’T LIKE THAT REFLECTION LOOKING BACK AT ME, SO I COVERED MY MIRRORS, AND I DIDN’T LOOK AT MYSELF ANYMORE.

—GAIL DEVERS

HOW IS TED AFFECTING YOUR PATIENTS’ QUALITY OF LIFE?

Get a clear picture of the burden of TED and how it could be impacting your patients’ lives. Ask them about their:

  • Ability to perform daily activities (do they have trouble driving, reading, caring for loved ones, or doing their job?)
  • Perception of their appearance and self-confidence (do they avoid being in pictures or attending social events?)
  • Emotional well-being (are they feeling depressed and/or anxious?)

To help patients and caregivers manage TED and improve their journey, download the TED Life Management Guidebook. Download now >

66%

OF PATIENTS SUFFERED A HIGH IMPACT ON DAILY LIFE5*

42%

OF PATIENTS WITH TED EXPERIENCED
ANXIETY AND/OR DEPRESSION6†

36%

OF PATIENTS REPORTED
MENTAL HEALTH ISSUES5*

*Based on a retrospective chart review of 714 US patients by assessing physician-perceived impact of moderate to severe TED on patients’ quality of life (QOL). High overall QOL impact score ≥4/7, where 1 meant “not at all impaired” and 7 meant “extremely impaired.”5

Based on an online QOL assessment survey of 100 patients including all levels of TED severity.6

Image of LaQuilla, a real patient, discussing the emotional side of Thyroid Eye Disease

“I never went out; I wouldn’t let anybody see me. I covered all the mirrors in the house because I didn’t want to see myself.” —LaQuilla, a TED patient

Signs and symptoms of TED may not always be visible. It’s important to ask your patients if they have had or are experiencing any new or worsening manifestations of TED, and how TED symptoms may be impacting their daily lives5,7-9

START CO-MANAGING WITH A TED SPECIALIST

  1. Kahaly GJ, Petrak F, Hardt J, Pitz S, Egle UT. Psychosocial morbidity of Graves’ orbitopathy. Clin Endocrin (Oxf). 2005;63(4):395-402.
  2. Estcourt S, Vaidya B, Quinn A, Shepherd M. The impact of Thyroid Eye Disease upon patients’ wellbeing: a qualitative analysis. Clin Endocrin (Oxf). 2008;68(4):635-639.
  3. Estcourt S, Hickey J, Perros P, Dayan C, Vaidya B. The patient experience of services for Thyroid Eye Disease in the United Kingdom: results of a nationwide survey. Eur J Endocrinol. 2009;161(3):483-487. 
  4. Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF, Wiersinga W. Long-term effects of Graves’ ophthalmopathy on health-related quality of life. Eur J Endocrinol. 2002;146(6):751-757.
  5. Wang Y, Padnick-Silver L, Francis-Sedlak M, Holt RJ, Foley C, Douglas RS. Inflammatory and noninflammatory Thyroid Eye Disease: comparison of disease signs, symptoms, and quality of life in patients in the United States. Endocrin Pract. 2022;28(9):842-846.
  6. Cockerham KP, Padnick-Silver L, Stuertz N, Francis-Sedlak L, Holt RJ. Quality of life in patients with chronic Thyroid Eye Disease in the United States. Ophthalmol Ther. 2021;10(4):975-987.
  7. Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velázquez-Villoria Á, Galofré JC. Graves’ ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol. 2015;2015:249125.
  8. Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362(8):726-738.
  9. Thyroid Eye Disease. National Organization for Rare Disorders. 2020. Accessed December 8, 2022. https://rarediseases.org/rare-diseases/thyroid-eye-disease